Navigation path

Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information

N-{2-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-N'-(5-methyl-3-isoxazolyl) urea hydrochloride monohydrate

EU orphan designation number: EU/3/10/747
Active ingredient: N-{2-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-N'-(5-methyl-3-isoxazolyl) urea hydrochloride monohydrate
Indication: Treatment of renal cell carcinoma
Sponsor: EUSA Pharma (UK) Limited
Ground Floor, Suite F, Breakspear Park, Breakspear Way, Hemel Hempstead, HP2 4TZ, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
11/06/2010 Orphan designation EMEA/OD/148/09 (2010)3840 of 09/06/2010
07/03/2012 Transfer of orphan designation EMEA/OD/148/09/T/01 (2012)1538 of 05/03/2012
04/02/2013 Change of name and/or address of sponsor
26/09/2014 Transfer of orphan designation EMA/OD/148/09/T/02 (2014)7016 of 24/09/2014
02/02/2016 Transfer of orphan designation EMA/OD/148/09/T/03 (2016)678 of 29/01/2016
24/04/2017 Removal of orphan designation from Community Register